Email info@neudata.co
Request a trial

Are Form 5500s a leading indicator for investors?

Julia Asri Meigh, Head of ESG and Macro Research (New York)

Neudata Literature Review
Post feature

We summarise a study that investigated whether a company’s Form 5500, and the metadata reported within the disclosure, provides equity investors with an information advantage.

LITERATURE

In this Literature Review, we discuss the July 2019 paper from

Request a Neudata trial

We'd like to know a bit more about you and your business, so we can deal with your request efficiently.
We take your privacy seriously and handle your personal data in line with our privacy statement.

We use your email address as part of allowing you access to your account and in order to provide you details with our products that might be of interest to you

Already got an account? Sign in now